Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.71 |
| ▸ | MEN1 | O00255 | 3/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | ATM | Q13315 | 1/20 | 0.68 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.62 |
| ▸ | CNR2 | P34972 | 11/20 | 0.56 |
| ▸ | CNR1 | P21554 | 2/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5012036 | 1.00 | MAPT (0.71) | MAPTMEN1KMT2ALMNAPOLB | |
| SCHEMBL18261960 | 1.00 | MAPT (0.71) | MAPTMEN1KMT2ALMNAPOLB | |
| SCHEMBL1149826 | 0.99 | MAPT (0.73) | MAPTMEN1KMT2ALMNAPOLB | |
| SCHEMBL11413547 | 0.95 | MAPT (0.75) | MAPTMEN1KMT2ALMNAPOLB | |
| SCHEMBL3039635 | 0.93 | MAPT (0.59) | MAPTMEN1KMT2ALMNAPOLB | |
| SCHEMBL9397206 | 0.89 | MAPT (0.79) | MAPTMEN1KMT2ALMNAPOLB | |
| SCHEMBL18261959 | 0.86 | MAPT (0.52) | MAPTMEN1KMT2ALMNAPOLB | |
| SCHEMBL8179196 | 0.84 | MAPT (0.71) | MAPTMEN1KMT2ALMNAPOLB | |
| SCHEMBL149167 | 0.84 | MAPT (1.00) | MAPTMEN1KMT2ALMNAPOLB | |
| SCHEMBL29666347 | 0.84 | MAPT (1.00) | MAPTMEN1KMT2ALMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240085670-A1 | METHODS OF MAKING A LOW-COST MINIATURE ACCOMMODATING OPTICAL IMAGING SYSTEM | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-03-14 | — | — | US | claimed |
| US-20240085670-A1 | METHODS OF MAKING A LOW-COST MINIATURE ACCOMMODATING OPTICAL IMAGING SYSTEM | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-03-14 | — | — | US | disclosed |
| EP-2128132-B1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | ADEKA CORP (JP) | 2014-01-15 | — | — | EP | disclosed |
| US-8133656-B2 | Oxime ester compound and photopolymerization initiator containing the same | ADEKA CORPORATION (JP) | 2012-03-13 | — | — | US | disclosed |
| US-20100075254-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2010-03-25 | — | — | US | disclosed |
| EP-2128132-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR COMPRISING THE COMPOUND | Adeka Corporation (JP) | 2009-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100075254-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | CYP4A11, OXER1, NR2E3 | MAPT 4252/4885MEN1 4584/4885KMT2A 3265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.